这是一篇来自已证抗体库的有关
人类 CEACAM1的综述，是根据17篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合CEACAM1 抗体。
CEACAM1 同义词: BGP; BGP1; BGPI
安迪生物R&D
| 小鼠 单克隆（283340） | | 安迪生物R&D CEACAM1抗体（R&D Systems, MAB2244)被用于被用于流式细胞仪在人类样本上 (图 st8). Oncoimmunology (2022) ncbi |
赛默飞世尔
| 小鼠 单克隆（283340） | | 赛默飞世尔 CEACAM1抗体（ThermoFisher Scientific, 283340)被用于被用于流式细胞仪在人类样本上 (图 5e). Cell Death Dis (2021) ncbi |
圣克鲁斯生物技术
| 小鼠 单克隆（E-10） | | 圣克鲁斯生物技术 CEACAM1抗体（Santa Cruz Biotechnology, sc-166404)被用于被用于免疫印迹在人类样本上. Tumour Biol (2015) ncbi |
| 小鼠 单克隆（GM8G5） | | 圣克鲁斯生物技术 CEACAM1抗体（Santa Cruz Biotechnology, GM8G5)被用于被用于免疫沉淀在人类样本上浓度为1 ug. Ann Surg Oncol (2014) ncbi |
| 小鼠 单克隆（GM8G5） | | 圣克鲁斯生物技术 CEACAM1抗体（Santa Cruz Biotechnology, GM8G5)被用于被用于免疫沉淀在人类样本上. Mod Pathol (2014) ncbi |
美天旎
| 小鼠 单克隆（TET2） | | 美天旎 CEACAM1抗体（Miltenyi Biotec, TET2)被用于被用于流式细胞仪在猕猴样本上 (图 1a). J Immunol (2017) ncbi |
丹科医疗器械技术服务（上海）有限公司
| 小鼠 单克隆（II-7） | | 丹科医疗器械技术服务（上海）有限公司 CEACAM1抗体（DAKO, II-7)被用于被用于免疫组化在人类样本上浓度为1:40 (图 1f). Diagn Pathol (2019) ncbi |
| 小鼠 单克隆（II-7） | | 丹科医疗器械技术服务（上海）有限公司 CEACAM1抗体（Dako, M7072)被用于被用于免疫组化在人类样本上浓度为0.2 ug/ml (表 2). PLoS ONE (2016) ncbi |
| 小鼠 单克隆（II-7） | | 丹科医疗器械技术服务（上海）有限公司 CEACAM1抗体（Dako, II-7)被用于被用于免疫组化在人类样本上 (图 4). Br J Cancer (2016) ncbi |
| 小鼠 单克隆（II-7） | | 丹科医疗器械技术服务（上海）有限公司 CEACAM1抗体（Dako, clone II-7)被用于被用于免疫组化-石蜡切片在人类样本上. Am J Surg Pathol (2015) ncbi |
| 小鼠 单克隆（II-7） | | 丹科医疗器械技术服务（上海）有限公司 CEACAM1抗体（Dako, M7072)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:400. Virchows Arch (2014) ncbi |
赛信通（上海）生物试剂有限公司
| 小鼠 单克隆（CB30） | | 赛信通（上海）生物试剂有限公司 CEACAM1抗体（Cell Signaling, CB30)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 4). Oncoimmunology (2016) ncbi |
| 小鼠 单克隆（CB30） | | 赛信通（上海）生物试剂有限公司 CEACAM1抗体（Cell Signaling Technologies, 2383)被用于被用于免疫印迹在小鼠样本上浓度为1:500. Cardiovasc Diabetol (2015) ncbi |
| 小鼠 单克隆（CB30） | | 赛信通（上海）生物试剂有限公司 CEACAM1抗体（Cell Signaling Technologies, 2383)被用于被用于免疫印迹在小鼠样本上浓度为1:500. BMC Endocr Disord (2015) ncbi |
| 小鼠 单克隆（CB30） | | 赛信通（上海）生物试剂有限公司 CEACAM1抗体（Cell Signaling, 2383)被用于被用于免疫印迹在人类样本上. Tumour Biol (2015) ncbi |
碧迪BD
| 小鼠 单克隆（B1.1/CD66） | | 碧迪BD CEACAM1抗体（BD Biosciences, 551480)被用于被用于流式细胞仪在人类样本上 (图 1c). EMBO Mol Med (2016) ncbi |
| 小鼠 单克隆（B1.1/CD66） | | 碧迪BD CEACAM1抗体（BD, 551480)被用于被用于流式细胞仪在人类样本上 (图 st1). Exp Cell Res (2016) ncbi |
| 小鼠 单克隆（B1.1/CD66） | | 碧迪BD CEACAM1抗体（BD, 551479)被用于被用于流式细胞仪在人类样本上浓度为1:1000. Cytometry A (2015) ncbi |
Pinkert J, Boehm H, Trautwein M, Doecke W, Wessel F, Ge Y,
et al. T cell-mediated elimination of cancer cells by blocking CEACAM6-CEACAM1 interaction. Oncoimmunology. 2022;11:2008110
pubmed 出版商 Lake C, Voss K, Bauman B, Pohida K, Jiang T, Dveksler G,
et al. TIM-3 drives temporal differences in restimulation-induced cell death sensitivity in effector CD8+ T cells in conjunction with CEACAM1. Cell Death Dis. 2021;12:400
pubmed 出版商 Oyama Y, Nishida H, Kusaba T, Kadowaki H, Arakane M, Okamoto K,
et al. Colon adenoma and adenocarcinoma with clear cell components - two case reports. Diagn Pathol. 2019;14:37
pubmed 出版商 Dross S, Munson P, Kim S, Bratt D, Tunggal H, Gervassi A,
et al. Kinetics of Myeloid-Derived Suppressor Cell Frequency and Function during Simian Immunodeficiency Virus Infection, Combination Antiretroviral Therapy, and Treatment Interruption. J Immunol. 2017;198:757-766
pubmed 出版商 Wang L, Ma N, Okamoto S, Amaishi Y, Sato E, Seo N,
et al. Efficient tumor regression by adoptively transferred CEA-specific CAR-T cells associated with symptoms of mild cytokine release syndrome. Oncoimmunology. 2016;5:e1211218
pubmed Li L, Qi X, Sun W, Abdel Azim H, Lou S, Zhu H,
et al. Am80-GCSF synergizes myeloid expansion and differentiation to generate functional neutrophils that reduce neutropenia-associated infection and mortality. EMBO Mol Med. 2016;8:1340-1359
pubmed 出版商 Rigden H, Alias A, Havelock T, O Donnell R, Djukanovic R, Davies D,
et al. Squamous Metaplasia Is Increased in the Bronchial Epithelium of Smokers with Chronic Obstructive Pulmonary Disease. PLoS ONE. 2016;11:e0156009
pubmed 出版商 Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9
pubmed 出版商 Ohlsson L, Hammarström M, Lindmark G, Hammarström S, Sitohy B. Ectopic expression of the chemokine CXCL17 in colon cancer cells. Br J Cancer. 2016;114:697-703
pubmed 出版商 He J, Quintana M, Sullivan J, L Parry T, J Grevengoed T, Schisler J,
et al. MuRF2 regulates PPARγ1 activity to protect against diabetic cardiomyopathy and enhance weight gain induced by a high fat diet. Cardiovasc Diabetol. 2015;14:97
pubmed 出版商 Quintana M, He J, Sullivan J, Grevengoed T, Schisler J, Han Y,
et al. Muscle ring finger-3 protects against diabetic cardiomyopathy induced by a high fat diet. BMC Endocr Disord. 2015;15:36
pubmed 出版商 Moser B, Schiefer A, Janik S, Marx A, Prosch H, Pohl W,
et al. Adenocarcinoma of the thymus, enteric type: report of 2 cases, and proposal for a novel subtype of thymic carcinoma. Am J Surg Pathol. 2015;39:541-8
pubmed 出版商 Nemes E, Kagina B, Smit E, Africa H, Steyn M, Hanekom W,
et al. Differential leukocyte counting and immunophenotyping in cryopreserved ex vivo whole blood. Cytometry A. 2015;87:157-65
pubmed 出版商 Aqil M, Elseth K, Arjunakani A, Nebres P, Amegashie C, Thanki D,
et al. A549 cells adapted to high nitric oxide show reduced surface CEACAM expression and altered adhesion and migration properties. Tumour Biol. 2015;36:1871-9
pubmed 出版商 Seipel A, Samaratunga H, Delahunt B, Wiklund F, Wiklund P, Lindberg J,
et al. Immunohistochemical profile of ductal adenocarcinoma of the prostate. Virchows Arch. 2014;465:559-65
pubmed 出版商 Kiriyama S, Yokoyama S, Ueno M, Hayami S, Ieda J, Yamamoto N,
et al. CEACAM1 long cytoplasmic domain isoform is associated with invasion and recurrence of hepatocellular carcinoma. Ann Surg Oncol. 2014;21 Suppl 4:S505-14
pubmed 出版商 Borgogna C, Lanfredini S, Peretti A, de Andrea M, Zavattaro E, Colombo E,
et al. Improved detection reveals active ?-papillomavirus infection in skin lesions from kidney transplant recipients. Mod Pathol. 2014;27:1101-15
pubmed 出版商
